Skopos Labs, Inc. 4 D Molecular Therapeutics, Inc. Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 4,217 shares of FDMT stock, worth $48,622. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,217
Previous 4,217
-0.0%
Holding current value
$48,622
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FDMT
# of Institutions
125Shares Held
41.2MCall Options Held
19KPut Options Held
38.3K-
Black Rock Inc. New York, NY4.9MShares$56.5 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA4.63MShares$53.4 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$52.6 Million0.37% of portfolio
-
Goldman Sachs Group Inc New York, NY4.16MShares$48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$31.6 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $373M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...